|
BY: Ben Mook
POSTED: September 11, 2011 Tags: biotech, center for vaccine development, hypodermic needle, kirsten lyke, malaria, malaria vaccine, national institutes of health, naval medical research center, PfSPZ, rockville, sanaria inc, u.s. military malaria vaccine program, University of Maryland School of Medicine, vaccine
![]()  A Rockville biotech firm whose malaria vaccine works by triggering an immune response with the saliva from 1,000 irradiated mosquitoes, is safe and shows promise, according to a research study published in the journal Science. Sanaria Inc. published the phase I trial study last week in collaboration with Center for Vaccine Development at the University [...]
|